The goal of this program project is to gain a better understanding of the relationship between the persistence of neurotropic virus and the development of neurologic disease in the elderly. The proposed studies center on four highly neurotropic viruses from two families (herpesviruses and picornaviruses) that are associated with serious morbidity and occasional mortality in the elderly. Human and animal subjects will be studies clinically and by using virologic, molecular, and immunologic techniques. We will prospectively study the association of morbidity in the aging with varicella-zoster virus (VZV) persistence. We will also prospectively analyze immune responsiveness to virus in both the elderly and young adult with and without disease. We will study molecular restriction of herpes virus in the nervous system and age-related dysfunction in response to virus infection. We will carry out a molecular analysis of wild and mutant polioviruses and study the influence of age on pathogenesis. Finally in an attempt to eradicate VZV-induced disease in the elderly, we will vaccinate a trial population with live virus vaccine and study their immune response. At the same time, a complete library of VZV genes will be developed, and VZV glycoprotein genes will be cloned into vectors and the expressed genes will be studied immunologically. This proposal melds the skills and strategies of investigators with expertise in neurology, dermatology, preventive medicine, aging, molecular virology, immunology, genetics and clinical investigation. This concentrated effort is focused on prospective studies towards determining the pathogenesis and eventual prevention of viral diseases of the nervous system in the elderly.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG007347-02
Application #
3091167
Study Section
Aging Review Committee (AGE)
Project Start
1988-04-01
Project End
1993-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Yang, Q; Sarnow, P (1997) Location of the internal ribosome entry site in the 5' non-coding region of the immunoglobulin heavy-chain binding protein (BiP) mRNA: evidence for specific RNA-protein interactions. Nucleic Acids Res 25:2800-7
Haller, A A; Sarnow, P (1997) In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. Proc Natl Acad Sci U S A 94:8521-6
McBratney, S; Sarnow, P (1996) Evidence for involvement of trans-acting factors in selection of the AUG start codon during eukaryotic translational initiation. Mol Cell Biol 16:3523-34
Levin, M J; Murray, M; Zerbe, G O et al. (1994) Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis 170:522-6
Hayward, A R; Buda, K; Levin, M J (1994) Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults. Viral Immunol 7:31-6
Zhang, Y; Cosyns, M; Levin, M J et al. (1994) Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 98:128-33
Hayward, A R; Zerbe, G O; Levin, M J (1994) Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods 170:27-36
Somekh, E; Levin, M J (1993) Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine. J Med Virol 40:241-3
Oh, S K; Sarnow, P (1993) Gene regulation: translational initiation by internal ribosome binding. Curr Opin Genet Dev 3:295-300
Mahalingam, R; Wellish, M; Lederer, D et al. (1993) Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. J Virol 67:2381-4

Showing the most recent 10 out of 67 publications